The largest database of trusted experimental protocols

12 protocols using cgp55845

1

Microinjection of CB1 and GABA-B Antagonists in Dentate Gyrus

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used the 4-methyl-1-H-pyrasole- 3-carboxamide (AM251) as a synthetic CB1 receptor antagonist prepared from Sigma, USA and the GABAB receptor antagonist (2S)-3-[[(1S)-1-(3,4-dichlorophenyl) ethyl]amino-2-hydroxypropyl](phenylmethyl) phosphinic acid hydrochloride (CGP55845; Sigma, USA). CGP55845 and AM251 were first dissolved in DMSO (dimethylsulfoxide) (Sigma, USA), followed by diluting in saline (0.9% NaCl). The concentration of DMSO was < 10%. DMSO and saline were applied as the vehicle. Microinjection of the drugs into the DG was done through a 27-gauge stainless steel injector that was attached to Hamilton microsyringe (1 µl) by PE-20 tubing about 20 min before HFS. Therefore, 0.5 µl of the drugs was microinjected unilaterally using a microsyringe pump and Hamilton syringes at 0.5 µl/min for 1 min. After combination of the drugs, their amount was twice and their final amount was the same (0.5 µl). We left the injection syringe in position for 60 s prior to withdrawal for minimizing dragging of the administrated solutions along the injection tract. The used solutions were prepared promptly before their usage. The concentrations of the drugs was according to earlier investigations: AM251: 0/1 µg/rat [28 (link), 32 (link), 33 (link)], and CGP55845: 1 µg/rat [28 (link), 34 (link)].
+ Open protocol
+ Expand
2

Electrophysiological Recording in Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reagents used for aCSF, the internal pipette solution, dopamine hydrochloride, sulpiride, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), APV, CGP-55845, and picrotoxin (PTX) were purchased from Sigma-Aldrich (Oakville, ON, Canada). All drugs were prepared fresh by dissolving them in distilled water.
+ Open protocol
+ Expand
3

Receptor Blockade in Electrophysiology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Where applicable, CGP 55845 (2 µM; Sigma-Aldrich, Germany), DPCPX (100 nM; Biotrend) or SCH 58261 (50 nM, Tocris Cookson, Bristol, UK) was bath perfused to selectively block GABAB, A1 or A2A receptors, respectively. Bath perfusion of NBQX (10 μM; Biotrend, Germany), D-APV (50 µM; Tocris Cookson, Bristol, UK) or S-MCPG (500 μM; Biotrend) was used to block AMPARs, NMDARs or metabotropic GluRs, respectively. Nifedipine (10 µM; Sigma-Aldrich, Germany) was used to block L-type voltage-gated Ca2+ channels.
+ Open protocol
+ Expand
4

Studying Neuronal Synaptic Transmission

Check if the same lab product or an alternative is used in the 5 most similar protocols
The normal aCSF comprised (in mM) 124 NaCl, 3.5 KCl, 1 MgCl2, 1.6 CaCl2, 26 NaHCO3, 1.25 NaH2PO4 and 10 glucose (pH 7.35; osmolarity 305 mOsm) to which 6‐cyano‐7‐nitro‐quinoxaline‐2,3‐dione (CNQX; 15 µM), 2‐amino‐5‐phosphono‐valeric acid (D‐APV; 50 µM), Picrotoxin (100 µM) and 3‐Aminopropyl)(diethoxymethyl) phosphinic acid hydrate (CGP‐55845; 1 μM) were added to block synaptic transmission. We used 1.6 mM CaCl2 in the aCSF because in bicarbonate buffer system this concentration yields 1.2 mM free Ca2+, corresponding to the baseline interstitial brain Ca2+ concentration measured in vivo (e.g., Jones & Keep, 1988). In most experiments, as indicated, the aCSFs contained also the HCN channel blocker 4‐4thylphenylamino‐1,2‐dimethyl‐6‐methylamino‐pyrimidinium chloride (ZD7288; 50 μM). The ACSFs designed to block voltage‐gated Ca2+ channels contained also NiCl2 (200 µM) and CdCl2 (200 µM). In K+‐free aCSF KCl was omitted. Picrotoxin, CGP‐55845, NiCl2, CdCl2 and ouabain were obtained from Sigma‐Aldrich Ltd. (Rehovot, Israel), CNQX and APV from Alomone Labs (Jerusalem, Israel), ZD7288 and XE991 from Tocris Bioscience (Bristol, UK), and BAPTA tetra‐potassium salt from Thermo Fisher Scientific (Waltham, MA).
+ Open protocol
+ Expand
5

Bioluminescent Neuronal Signaling Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The luciferase substrate, coelenterazine (CTZ), was purchased from NanoLight Technology (Pinetop, AZ): Coelenterazine free base, the natural form of CTZ (NanoLight # 303), was dissolved at 50 mM in NanoFuel (NanoLight # 399); CTZ was further diluted 1:50 in culture medium for a 1 mM working solution that was further diluted 1:100 when added to MEAs for a final concentration of 10 μM. The same dilutions were carried out with just NanoFuel for vehicle. Cocktail of synaptic blockers included NBQX (abcam # ab120046), D-AP5 (abcam # ab120003), Gabazine (Sigma Aldrich # S106), CGP 55845 (Sigma Aldrich # SML0594) and Strychnine (Sigma Aldrich # S0532). Botulinum Neurotoxin (BoNT/A1) was purchased from Metabiologics (Madison, Wisconsin).
+ Open protocol
+ Expand
6

GABA Receptor Pharmacology and Immunohistochemistry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chloral hydrate was purchased from Sinopharm Chemical Reagent Co (Shanghai, China). IBO (dissolved in PBS, 5 μg/μl). Gabazine (S106, GABA-A receptor antagonist, diluted in DMSO, 1 M), and CGP55845 (SML0594, GABA-B receptor antagonist, diluted in DMSO, 1 M) were purchased from Sigma-Aldrich Co (St. Louis, MO). Anti-GABA-A receptor alpha 1 (ab94585, mouse-origin monoclonal antibody, 1:200), anti-GABA-B receptor 1 (ab55051, mouse-origin monoclonal antibody, 1:200), and anti-Brn3a antibody (ab81213, rabbit-origin monoclonal antibody, 1:200) were obtained from Abcam (Cambridge, MA).
+ Open protocol
+ Expand
7

Striatal Slice Voltammetry in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isoflurane (Patterson Veterinary, Devens, MA) anesthetized mice were sacrificed by decapitation and brains were rapidly removed, sectioned into thick coronal striatal slices (300–400μm; Leica VT1000S, Vashaw Scientific, Norcross, GA), incubated for 60 minutes at 34 °C in pre-oxygenated (95% O2/5% CO2) artificial cerebral spinal fluid (aCSF). The aCSF consisted of (in mM): NaCl (126), KCl (2.5), NaH2PO4 (1.2), MgCl2 (1.2), NaHCO3 (25), D-glucose (11), L-ascorbic acid (0.4), with pH adjusted to ~7.4. Cutting solution also contained either MK801 (10 μM; (5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine; Abcam, Cambridge, UK) or kynurenic acid (2 mM) for blockade of ionotropic glutamate receptors. At the end of the incubation period, tissue was transferred to aCSF (34 °C) without glutamate receptor blockers. The following concentrations of drugs were bath applied for slice voltammetry experiments where specified: Baclofen (30 μM), CGP55845 (200 nM), quinpirole (10 μM), sulpiride (600 nM; Sigma), 2β-propanoyl-3β-(2-naphthyl)-tropane (WF-23) (10 nM – 3 μM; Huw M. L. Davies, Emory University, Atlanta DA), 2β-propanoyl-3β -(4-tolyl)-tropane (PTT) (100 nM – 30 μM; Huw M. L. Davies), cocaine (300 nM - 30 μM; NIDA, Rockville, MD USA).
+ Open protocol
+ Expand
8

Intrathecal GABA Modulators for Spinal Protection

Check if the same lab product or an alternative is used in the 5 most similar protocols
GABA receptor antagonists and GABA transaminase inhibitor were delivered via an intrathecal catheter placed at thoracic T1 to T4 spinal level inserted through a small incision in dura mater at thoracic spinal level 5. The lowest therapeutic dose was chosen based on literatures30 (link)–33 (link). For the GABAA/B receptor antagonists 1000 microgram of GABAA antagonist Bicuculline (Sigma-Aldrich) or 3000 microgram of GABAB antagonist CGP55845 (Sigma-Aldrich) were dissolved in 2 milliliters of normal saline and warmed to 37° Celsius, were infused over 5 minutes using a syringe pump. Given that the peak dorsal horn drug concentration occurs 30 minutes after intrathecal administrations, each antagonist was applied 30 minutes before starting Ischemia/reperfusion and reapplied at 60 minute intervals. GABA transaminase inhibitor, GABAculine, was used as inhibition of GABA transaminase reduces the degradation of GABA leading to increased neuronal GABA concentrations34 (link). 5 milligrams of GABAculine (Enzo) was dissolved in 1milliliter DMSO and 4 milliliter saline, 2 milligrams GABAculine was infused over 5 minutes using a syringe pump, 30 minutes prior to Ischemia/reperfusion, with no spinal cord stimulation, and reapplied at 60 minutes interval.
+ Open protocol
+ Expand
9

Pharmacological Manipulation of Synaptic Transmission

Check if the same lab product or an alternative is used in the 5 most similar protocols
MK-801 (10 μM), an uncompetitive NMDAR antagonist, QX314 (6 µM), voltage-gated Na+ channel blocker, bicuculline (10 µM), a competitive GABAa receptor antagonist, CGP 55845, a selective GABAb receptor antagonist (5 µM), and DNQX (20 µM), a competitive AMPA and kainate receptor antagonist, were obtained from Sigma (St. Louis, MO, USA). These drugs, used for the electrophysiology experiments, were diluted in distilled water and applied via a bath.
+ Open protocol
+ Expand
10

Compound E139 Synthesis and Application

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compound E139 was synthesized in house [11 (link)]; stock solutions were prepared in dimethyl sulfoxide (Sigma; St. Louis, Mo., USA), aliquoted into 40-μl portions, stored at −20°C, and used within 2 weeks. Paclitaxel and GABA were purchased from Tocris (Bristol, UK), CNQX from Tocris (Ellisville, Mo., USA); ethanol, Cremophor EL, CGP 55845, the salts used in the preparation of artificial cerebrospinal fluid (aCSF), and recording solutions were from Sigma (St. Louis, Mo., USA). All stock solutions were diluted to the desired concentrations with aCSF before use and applied to the tissue slices by bath perfusion.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!